Original filing (PDF)20260115110044NAL0023210834001

Immunos Therapeutics US, Inc.

Name: Immunos Therapeutics US, Inc. — Immunos Therapeutics, Form 5500 (2025)
Creator: Immunos Therapeutics US, Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Immunos Therapeutics US, Inc. 401(k) Plan

401(k) retirement plan · Immunos Therapeutics US, Inc.'s Immunos Therapeutics US, Inc. 401(k) Plan filed a Form 5500 for plan year 2025.

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

People on this filing

Darlene Ropelewski signed Immunos Therapeutics US, Inc.'s 2025 Form 5500 as plan administrator.

Darlene Ropelewski — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Immunos Therapeutics US, Inc.'s EIN is 87-4006225.

EIN 87-4006225

Plan number 001

Plan year 2025

ACK ID 20260115110044NAL0023210834001

Official Form 5500 document

Download the official 2025 Form 5500 (PDF) for Immunos Therapeutics US, Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2025 Form 5500 (PDF)

Plan features

Immunos Therapeutics US, Inc.'s plan includes profit-sharing, a 401(k) feature, ERISA 404(c) participant direction, a default investment (QDIA), automatic enrollment.

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for IMMUNOS THERAPEUTICS US, INC..

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Helping the score